Kevin Churchwell, an insider of Cyclerion Therapeutics, Inc., just received 10,000 options from the company. The strike price of the options received was $3.97, and these expire on June 24, 2031. Churchwell now owns at least 10,000 options on the company.
Some additional info was provided as follows:
The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Cyclerion Therapeutics, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
Current report, items 7.01 and 9.01
- Sept. 30, 2021